Kim Brouwer

  1. Pharmacokinetic Modeling of Bile Acid Disposition in Human Hepatocytes and Effects of Modulators
    Intercept Pharmaceuticals, Inc., 8/15/2016-8/15/2017
  2. UNC-Duke-Hamner Collaborative Clinical Pharmacology Postdoctoral Training Program (2-T32-GM086330-06)
    NIGMS, 7/1/2011-6/30/2021
  3. Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy (R35 GM122576-01)
    NIGMS, 04/05/2017-03/31/2022

Yanguang Cao

  1. Optimizing antibody-based therapy through a system platform of pharmacokinetics, pharmacodynamics and immunodynamics (1-R35-GM119661-01)
    NIGMS, 8/1/2016-5/31/2021

Mackenzie Cottrell

  1. Pharmacokinetics Testing for CONRAD A15-137, titled Exploratory Pharmakokinetic and Pharmacodynamic Study of Oral F/TAF for the Prevention of HIB Acquisition
    East Virginia Medical School, 3/15/2017-10/31/2018
  2. Work Order 4_Services with respect to the method development and linearity evaluation for CMX048 in mouse liver and kidney and mouse tissue sample analysis
    Chimerix, Inc., 5/1/2018-10/31/18
  3. Morse Vorinostat Study
    Bringham and Womens Hospital/NIAID, 12/1/2017-11/30/2018
  4. Animal Model for Testing SIV Latency Reversal Strategies
    University of Pittsburgh/NIAID, 8/1/2015-1/31/2019
  5. Systemic Prevention of HIV in Women
    Research Triangle Institute (RTI International), 7/24/2017-7/23/2020

Daniel Crona

A Prospective Multi-dose Study of Apixaban in Nephrotic Syndrome Patient
ACCP Research Institute, 9/15/18-9/14/2019

Julie Dumond

  1. Epigenomics of ethnic and racial disparities in ARV exposure and treatment outcomes
    University of California at San Francisco (UCSF), 8/31/2017-12/31/2018

Alan Forrest

  1. Optimizing Clinical Use of Polymyxin B: Teaching an Old Drug to Treat Superbugs (3004163909)
    University of Michigan (UMICH), 9/1/2016-5/31/2020
  2. New Tricks for ‘Old’ Drugs: PK/PD of Polymyxin Nonantibiotic Combinations (R01AI111965)
    Monash University, 8/1/2015-3/31/2018

Rao Gauri

  1. Design and Optimization of Polymyxin-based Triple Combination Regimens against Carbapenem Resistant Klebsiella Pneumoniae
    ACCP Research Institute, 9/15/2017-9/14/2018

Daniel Gonzalez

  1. Use of Physiologically-Based PK/PD Models to Streamline Drug Approvals (5-K23-HD083465-01-03)
    NICHD, 4/15/2015-2/29/2020

Angela Kashuba

  1. Long term persistence of HIV in the liver and the clinical impact on HIV-HBV co-infection
    University of Melbourne, 11/28/2016-12/31/2019
  2. Multi-Species Mechanisms of Drug Bio-distribution in HIV Tissue Reservoirs (5-R01-AI111891-01-04)NIAID, 3/15/2014-2/28/2019
  3. Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence (5-R01-AI122319-01-02)
    NIAID, 1/1/2016-12/31/2020

Federico Innocenti

  1. ACTO Appendix IIB to CALGB/SWOG C80405
    Alliance for Clinical Trials in Oncology Foundation, 6/1/2015-5/31/2018

Craig Lee

  1. Novel Biomarkers of Eicosanoid Metabolism in Coronary Artery Disease (16GRNT29300003)
    American Heart Association (AHA), 7/1/2016-6/30/2018

Merrie Mosedale

  1. SBIR: Standardization of a Fluidic In Vitro Exposure System for IVIVE Predictive Toxicity Data
    American Heart Association (AHA), 9/19/2017-8/31/2019
  2. Development of an In Vitro Platform for the Evaluation of Genetic Susceptibility Factors Associated with Adverse Drug Response
    Burroughs Wellcome Fund, 9/1/2017-8/31/2022

Herb Patterson

  1. Observational Registry of Treatment Patterns in U.S. Heart Failure Patients with Reduced Ejection Fraction
    Novartis Pharmaceuticals Corporation, 5/24/2015-3/30/2020

Adam Persky

  1. Use of worked examples and problem solving to teach clinical note writing
    American Association of Colleges of Pharmacy (AACP), 7/1/2018-6/30/2019

Jo Ellen Rodgers

  1. Influenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)
    Brigham and Womens Hospital, 2/15/2016-4/30/2018

Dhiren Thakker

  1. Use of Human Intestinal Tissue and Physiologically-Based Pharmacokinetic Modeling to Predict the Pharmacokinetics of Orally Administered Amoxicillin in Adults and Infants.
    PhRMA, 1/1/2017-12/31/2018

Paul Watkins

  1. University of North Carolina Clinical Center for DILIN RPPR-14 (4-U01-DK065201-14)
    NIDDKD, 9/30/2003-6/30/2018

Tim Wiltshire

  1. Systems Toxicogenomics of Endocrine Disrupting Chemicals in Brain (2015-3275-02)
    North Carolina State University (NCSU), 6/1/2016-4/30/2017
  2. Genetic Etiology of Cancer Drug Response (2011-2427-05)
    North Carolina State University (NCSU), 6/1/2016-4/30/2018

William Zamboni

  1. Quantitation of MRX-2843 and Metabolite M40 in Plasma in a Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MRX-2843 in Adult Subjects with Relapsed/Refractory Advanced and/or Metastatic Solid Tumors
    Meryx, Inc., 2/1/2018-2/1/2019
  2. Separation and Quantitation of ZY-010 Drug Forms in Rat Plasma (Associated, Released-Protein-Bound and Release-unbound Paclitaxel) Dual Filter Method
    ZY Therapeutics, Inc., 2/7/2017-2/6/2020
  3. Glolytics Exploratory Analysis to Address Whether the Mononuclear Phagocyte System (MPS)
    Glolytics, LLC, 1/10/2017- 1/9/2021
  4. ChemoGLO – Service Agreement
    ChemoGLO, LLC, 11/1/2016-10/31/2019